MedPath

AG-EZETIMIBE

AG-EZETIMIBE

Approved
DIN Number

02475898

Drug Class

Human

Market Date

Jul 20, 2018

Company
HC

angita pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02475898
AIG Number0149164001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AX09 EZETIMIBE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.05
Health Canada Classification

ACTIVE INGREDIENTS (1)

EZETIMIBEActive
Strength: 10 MG
Monograph: EZETIMIBE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.